부인과용 체어 및 테이블 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Gynecological Chairs And Tables Market Growth & Trends:

The global gynecological chairs and tables market size is expected to reach USD 1.04 billion by 2030 and is projected to grow at a CAGR of 6.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses specialized furniture tailored for various women's health procedures, including routine pelvic exams, pap smears, colposcopy, vaginal cancer screenings, biopsies, obstetrics, IUD insertion and removal, and cryotherapy. For instance, according to the American Society of Clinical Oncology (ASCO), globally, around 17,908 individuals received a diagnosis of vaginal cancer in 2020, and in 2023, an estimated 8,470 people in the U.S. alone are projected to be diagnosed with this condition.

Technological advancements enable integration with telemedicine platforms, allowing for remote examinations and consultations. With a focus on improving patient care and clinical outcomes, the market continues to evolve to meet the diverse needs of healthcare providers and patients in women's health.

Modern gynecological chairs and tables prioritize patient comfort during examinations and procedures. This includes features such as adjustable positioning, memory settings, and integrated heating for a more relaxed and positive patient experience. In addition, safety features such as weight capacity improvements and emergency stop buttons are crucial. Hence, the increasing focus of manufacturers on developing equipment that offers patient comfort and safety is anticipated to create wide growth opportunities in the near future.

Gynecological Chairs And Tables Market Report Highlights:

• Based on type, the gynecological chairs segment held the largest revenue share of 44.2% in 2023. These chairs offer enhanced comfort, accessibility, and support during various women's health procedures, promoting better patient experiences and clinical outcomes.
• The urology surgery segment is expected to grow at the fastest CAGR of 7.3% over the forecast period. The urology segment provides specialized chairs and tables tailored for urological procedures, ensuring precise positioning, accessibility, and patient comfort for optimal surgical outcomes.
• The others end-use segment held the largest revenue share of 59.9% in 2023. Hospitals, ambulatory surgical centers, and gynecology clinics benefit from specialized chairs and tables designed to enhance patient comfort, streamline procedures, and improve clinical efficiency.
• Based on end-use, the Department of Veterans Affairs (VA) segment is expected to grow at the fastest CAGR of 7.4% during the forecast period. The Department of Veterans Affairs (VA) utilizes specialized gynecological chairs and tables to provide comprehensive women's healthcare services to military veterans, ensuring tailored care and support for this unique patient population.
• In 2023, the North America region dominated the global market with a revenue share of 36.6%. This large share is attributed to advanced healthcare infrastructure, high adoption of innovative technologies, and increasing demand for women's health services.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Type
  • 1.1.2. Application
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Gynecological Chairs And Tables Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of gynecological disorders
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Growing awareness of gynecological disorders and treatments
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of products and gynecological treatments
    • 3.2.2.2. Lack of healthcare facilities and professionals in developing and underdeveloped countries
• 3.3. Gynecological Chairs And Tables Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Gynecological Chairs And Tables Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Gynecological Chairs And Tables Market: Type Movement Analysis
• 4.3. Gynecological Chairs And Tables Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Gynecological Chairs
  • 4.5.1. Gynecological Chairs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.1. Electric
    • 4.5.1.1.1. Electric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.2. Manual
    • 4.5.1.2.1. Manual Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Gynecological Tables
  • 4.6.1. Gynecological Tables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.1.1. Powered
    • 4.6.1.1.1. Powered Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.1.2. Non-powered
    • 4.6.1.2.1. Non-powered Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Operating Table Boot Stirrups
  • 4.7.1. Operating Table Boot Stirrups Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Gynecological Chairs And Tables Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Gynecological Chairs And Tables Market: Application Movement Analysis
• 5.3. Gynecological Chairs And Tables Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Urology Surgery
  • 5.5.1. Urology Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Pelvic Surgery
  • 5.6.1. Pelvic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Gynecological Chairs And Tables Market: End-use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Gynecological Chairs And Tables Market: End-use Movement Analysis
• 6.3. Gynecological Chairs And Tables Market by End-use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Department of Veterans Affairs (VA)
  • 6.5.1. Department of Veterans Affairs (VA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Office Based Surgery (OBS)
  • 6.6.1. Office Based Surgery (OBS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Gynecological Chairs And Tables Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Gynecological Chairs And Tables Market movement analysis
• 7.3. Gynecological Chairs And Tables Market: Regional Estimates & Trend Analysis
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Europe
  • 7.5.5. Europe Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. UK
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. UK Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Germany
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Germany Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. France
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. France Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Italy
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. Italy Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Spain
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Spain Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Denmark
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Denmark Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Sweden
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Sweden Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Norway
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Norway Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Mexico
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Mexico Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. Argentina
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Argentina Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Gynecological Chairs And Tables Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. STERIS
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Optomic
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Baxter (Hill Rom Holdings)
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. medifa
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Advin Health Care
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. MERIVAARA CORP.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Apothecaries Sundries Manufacturing Co.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Novak M.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Zhangjiagang Medi Medical Equipment Co., ltd.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Surgitech
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. The Brewer Company, LLC
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Midmark Corporation. (Ritter Midmark)
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Product benchmarking
    • 8.2.12.4. Strategic initiatives
  • 8.2.13. Clinton Industries, Inc.
    • 8.2.13.1. Company overview
    • 8.2.13.2. Financial performance
    • 8.2.13.3. Product benchmarking
    • 8.2.13.4. Strategic initiatives
  • 8.2.14. UMF Medical
    • 8.2.14.1. Company overview
    • 8.2.14.2. Financial performance
    • 8.2.14.3. Product benchmarking
    • 8.2.14.4. Strategic initiatives
  • 8.2.15. Hausmann Enterprises, LLC
    • 8.2.15.1. Company overview
    • 8.2.15.2. Financial performance
    • 8.2.15.3. Product benchmarking
    • 8.2.15.4. Strategic initiatives
  • 8.2.16. Bailey's Medical Supplies
    • 8.2.16.1. Company overview
    • 8.2.16.2. Financial performance
    • 8.2.16.3. Product benchmarking
    • 8.2.16.4. Strategic initiatives
  • 8.2.17. Metron Healthcare
    • 8.2.17.1. Company overview
    • 8.2.17.2. Financial performance
    • 8.2.17.3. Product benchmarking
    • 8.2.17.4. Strategic initiatives